The first commercially available solution for the detection of intracellular proteins for single-cell RNAseq experiments SAN DIEGO, CA – Proteintech Genomics, a subsidiary of Proteintech Group, Inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiProTM Human Fixed Cell Immune Profiling Antibody Cocktail. This cocktail contains 53 antibodies against intracellular and [...]

SepSolve Analytical has expanded its GC×GC product offering through the addition of a new modulator. The new INSIGHT-Thermal sits alongside SepSolve’s existing INSIGHT-Flow modulator, enabling the company to now provide GC×GC analysts with outstanding performance whatever their application needs, from research through to routine analyses. Both INSIGHT-Flow and INSIGHT-Thermal are fully compatible with GCs from [...]

New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® De novo Cloning and Amplification kit on the BioXp 3250 and BioXp 9600 systems. This cell-free [...]

Evident was established as a standalone company in April 2023, comprising the former Scientific Solutions business of Olympus, marking a significant milestone in the development of our new company. Building on our proven track record of innovation in imaging, instrumentation, and measurement solutions, we are excited to announce we have reorganized our internal structure into [...]

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior [...]

BAGNEUX, France, Genomic Vision (FR0011799907 – GV, the "Company"), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of transformed cells, announces having filed today a declaration of cessation of payments ("déclaration de cessation des paiements") with the Commercial Court of Nanterre. The employee representative bodies were informed on October [...]

Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the HiFi Solves consortium. This global consortium brings together researchers from 15 leading genomics research institutions across 11 countries to study the value HiFi-based [...]

Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Collaboration to accelerate discovery, enhance cost efficiencies, and improve turnaround times for genomic applications in the scientific community QIAGEN to present performance data for universal QIAseq library preparation panels running on other sequencing platforms at [...]

Company has signed virtual power purchase agreements (VPPAs) for a total of around 300 gigawatt hours (GWh) of renewable energy per year. Company signs virtual power purchase agreements for 300 gigawatt hours per year Wind and solar farms operational in Spain from 2025 Important milestone for strategic sustainability goal of Merck KGaA, Darmstadt, Germany, to [...]

DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth. Zurich, Switzerland – DKSH has announced today that it signed [...]